Stock doesn't seem to be able to break-through it's 200 day moving average. If we could just get on the other side of $13.50 and close above that level we might be back in a meaningful uptrend. Let's hope the last hour holds one more pop!
Docs are already comfortable with the first chloride channel activator on the market, Amitiza. 7 years and 7 million patients on it, very tough to compete against their clinical experience with this drug. And no diarrhea with Amitiza.